NCT02356159 2025-09-30
Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
National Institutes of Health Clinical Center (CC)
University of Chicago
National Institutes of Health Clinical Center (CC)
University of Chicago
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Duke University